Virtu Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,402
Closed -$45K 1891
2025
Q1
$45K Sell
10,402
-1,571
-13% -$6.34K ﹤0.01% 1023
2024
Q4
$38K Buy
+11,973
New +$40.2K ﹤0.01% 1199
2024
Q2
Sell
-19,536
Closed -$55K 1735
2024
Q1
$55K Buy
19,536
+3,227
+20% +$11K ﹤0.01% 1009
2023
Q4
$67K Buy
+16,309
New +$45.7K 0.01% 1124

Other funds holding ORGO

Virtu Financial's ORGO Position: Q2 2025 in Review

Virtu Financial sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 10,402 shares — an estimated $45K sold.

Virtu Financial first reported a position in ORGO in Q4 2023 and held it in 4 quarters. The position peaked at $67K in Q4 2023. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Virtu Financial reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Virtu Financial sold 10,402 Organogenesis Holdings shares in Q2 2025, an estimated $45K.
  • Virtu Financial first reported a position in Organogenesis Holdings in Q4 2023 and held it in 4 quarters.
  • Virtu Financial's Organogenesis Holdings position peaked at $67K in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.